SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'mktcap'
PRE (Prenetics Global) Market Cap
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Prenetics Global's share price for the quarter that ended in Sep. 2023 was $7.275. Prenetics Global's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 12.0 Mil. Therefore, Prenetics Global's market cap for the quarter that ended in Sep. 2023 was $87.4 Mil.
Prenetics Global's quarterly market cap
increased
from Mar. 2023 ($153.2 Mil) to Jun. 2023 ($160.4 Mil) but then
declined
from Jun. 2023 ($160.4 Mil) to Sep. 2023 ($87.4 Mil).
Prenetics Global's annual market cap
stayed the same
from Dec. 2020 ($0.0 Mil) to Dec. 2021 ($0.0 Mil) but then
increased
from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($274.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Prenetics Global's Enterprise Value for Today is $-18.9 Mil.
Prenetics Global Market Cap Historical Data
The historical data trend for Prenetics Global's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Prenetics Global's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prenetics Global Market Cap Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's Market Cap distribution charts can be found below:
* The bar in red indicates where Prenetics Global's Market Cap falls into.
Prenetics Global Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Prenetics Global's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prenetics Global (NAS:PRE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companyÂ’s debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Prenetics Global Market Cap Related Terms
Thank you for viewing the detailed overview of Prenetics Global's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Prenetics Global (Prenetics Global) Business Description
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRE has been successfully added to your 